These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Endoxan in the treatment of psoriatic arthritis and rheumatoid arthritis]. Maldykowa H; Chwalińska-Sadowska H Reumatologia; 1972; 10(3):253-7. PubMed ID: 4634603 [No Abstract] [Full Text] [Related]
23. [Treatment of arthropathic psoriasis with antimetabolites and glucocorticoids]. Sönnichsen N; Kluge K Dermatol Monatsschr; 1971 May; 157(5):334-7. PubMed ID: 5096974 [No Abstract] [Full Text] [Related]
24. [Value of depot synacthen therapy in dermatoses. A report of over 6-years' experiences]. Harnack K; Flegel P Dermatol Monatsschr; 1984; 170(4):237-43. PubMed ID: 6329833 [No Abstract] [Full Text] [Related]
25. An open study on the efficacy and safety of auranofin in treating psoriatic arthritis. Dequeker J; Gevers G Scand J Rheumatol Suppl; 1986; 63():85-95. PubMed ID: 3474779 [TBL] [Abstract][Full Text] [Related]
26. [Experience with the treatment of psoriatic arthritis using tigazon]. Shakhtmeĭster IIa; Pokryshkin VI; Pisarenko MF; Shakhtmeĭster SI Vestn Dermatol Venerol; 1986; (2):37-9. PubMed ID: 3705734 [No Abstract] [Full Text] [Related]
27. [Effectiveness of photochemotherapy in psoriatic erythroderma]. Marzeeva GI; Trofimova LIa; Kirsanova MM Vestn Dermatol Venerol; 1982 May; (5):8-12. PubMed ID: 6214104 [No Abstract] [Full Text] [Related]
29. Antimalarials in psoriatic arthritis. Trnavský K; Zbojanová M; Vlcek F J Rheumatol; 1983 Oct; 10(5):833-4. PubMed ID: 6644715 [No Abstract] [Full Text] [Related]
30. Ro 10-9359, an aromatic retinoid in the treatment of psoriatic arthritis. Clinical and immunological studies. Rosenthal M Arzneimittelforschung; 1982; 32(8):842-4. PubMed ID: 6890362 [TBL] [Abstract][Full Text] [Related]
31. [Deresinated naphthalan in the treatment of psoriatic arthritis]. Grigor'eva VD; Badalov NG Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (4):13-5. PubMed ID: 7846875 [TBL] [Abstract][Full Text] [Related]
32. [Intravenous use of high doses of corticosteroids in the treatment of severe cases of ankylosing spondylitis, rheumatoid and psoriatic arthritis]. Jajić I Reumatizam; 1983; 30(3):54-9. PubMed ID: 6612110 [No Abstract] [Full Text] [Related]
33. [The efficacy of diclonate P in psoriatic arthritis]. Burdeĭnyĭ AP Ter Arkh; 1994; 66(5):75-7. PubMed ID: 7940348 [TBL] [Abstract][Full Text] [Related]
34. Methotrexate in psoriatic arthritis: a retrospective study. Kragballe K; Zachariae E; Zachariae H Acta Derm Venereol; 1983; 63(2):165-7. PubMed ID: 6189337 [TBL] [Abstract][Full Text] [Related]
35. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry. Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864 [TBL] [Abstract][Full Text] [Related]
37. [Synacthene-Retard in mental confusion of aged patients]. Porte M; Juttner G; Michelangeli J; Krebs BP; Lavagna J; Capdeville C; Darcourt G Ann Med Psychol (Paris); 1979; 137(5):481-90. PubMed ID: 228577 [No Abstract] [Full Text] [Related]
38. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity. Glass D; Roffe L; Maini RN; Wraith DG; Nuki G Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487 [TBL] [Abstract][Full Text] [Related]
39. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis. Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967 [TBL] [Abstract][Full Text] [Related]
40. [Analysis of adverse factors affecting the result of therapy for West syndrome in children]. Michałowicz R; Ignatowicz R; Kmieć T; Kuczyński D Pol Tyg Lek; 1994 Jan 24-31; 49(4-5):93-5. PubMed ID: 8029150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]